Targeted therapies for pediatric psoriasis
Children who are recalcitrant to topical therapy for their moderate to severe plaque psoriasis and/or highly visible lesions may be candidates for systemic therapy.
Venous Eczema and Lipodermatosclerosis
Cutaneous changes are a common feature of chronic venous insufficiency and include venous eczema and lipodermatosclerosis. This review will address the presumed pathophysiology of these conditions, their clinical findings, and important management strategies.
Semin Cutan Med Surg 32:169-176 © 2013 Frontline Medical Communications
Targeted therapies for psoriatic arthritis: an update for the dermatologist
With many new medications either on the market or currently being evaluated by the Food and Drug Administration, the purpose of this article is to review PsA for the dermatologist, to identify the current therapies that are available, and to help select which patients may benefit from these medications.
The Impact of Biologics on the Quality of Life of Psoriasis Patients and the Economics of Psoriasis Care
Rapid advancements in fundamental immunological mechanisms have led to the development of new targets for treating psoriasis.